News

Pancreatic cancer is a very serious illness that starts in the pancreas, a small organ behind the stomach. The pancreas helps ...
Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.
As a chemist at Florida State, he pioneered techniques used in the large-scale production of Taxol, a blockbuster anti-cancer agent.
Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...
Within weeks of treating patients with CER-1236, the company hopes to start learning about its safety profile and gauge efficacy markers.
Corcept's ALS drug dazucorilant improved survival despite missing the main goal; ovarian cancer drug combo met its target in ...
Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by ...
A study in Oncogene shows that PPP2R1A mutations increase sensitivity to ATR inhibitors in ARID1A-mutant ovarian clear cell ...
Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...
An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.
An Ardmore mom and son participated to “Strike Out Cancer” at Wednesday night’s Women’s College World Series in Oklahoma City.
A Danish research team has cracked the full biosynthesis of Taxol enabling cheaper and eco-friendly production in yeast.